Cancer research is a booming industry, but for unfortunate reasons. Cancer has been around for far too long, but the individuals who work in this exclusive field of work, are doing their best to eradicate the illness. Some of the very best in advancements has come over the past few decades. Breakthrough cancer medications are changing the game by saving many more lives. These advanced medications just so happen to come in the form of antibody-based therapies or antibody-based conjugates. The United States is home to one of the very best in this dynamic industry, and this company is guided by one of the best in the business.
Dr. Clay Siegall is leading the charge in the eradication of the cancer illnesses. He is the current CEO, president and co-founder of Seattle Genetics. This company sits at the top of the industry’s apex thanks to its ingenuity, its innovations, and its leadership. Siegall is known by many as a doctor, a scientist, an entrepreneur and a philanthropist. He has also brought in over a billion dollars via public and private fundraising. Why is Dr. Siegall so focused on doing his job? Unfortunately, that should have never been a question to begin with. Anyone who’s practicing in this field should have an extreme focus to save lives. On the other hand, Siegall has dealt with this illness on a first-hand basis. His father suffered with cancer for years before his untimely passing. This illness has lit a fire under Siegall because he knows just how difficult cancer can be for the patient and for the family members.
Thanks to his gigantic heart, Siegall has been on a mission to wipe this illness out of existence. His profound principles of drug development, scientific innovation and rigorous research have changed the game. So, what does the future hold for cancer patients? The future for cancer patients is looking much more brighter thanks to Dr. Clay Siegall, Seattle Genetics and all of the other cancer-fighting organizations in the world.